#BEGIN_DRUGCARD DB08036

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C20H13N3O

# Chemical_IUPAC_Name:
3,13,23-triazahexacyclo[14.7.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tricosa-1(16),2(10),4,6,8,11(15),17,19,21-nonaen-12-one

# Chemical_Structure:
Not Available

# Creation_Date:
2010-09-15 15:27:56 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one

# HET_ID:
K2C

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C20H13N3O/c24-20-17-12(9-21-20)15-10-5-1-3-7-13(10)22-18(15)19-16(17)11-6-2-4-8-14(11)23-19/h1-8,22-23H,9H2,(H,21,24)

# InChI_Key:
InChIKey=MEXUTNIFSHFQRG-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
8042

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
311.3367

# Molecular_Weight_Mono:
311.105862053

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
3.57

# Predicted_LogS:
-4.8

# Predicted_Water_Solubility:
5.28e-03 g/l

# Primary_Accession_No:
DB08036

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
3815

# PubChem_Substance_ID:
99444507

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
O=C1NCC2=C3C(NC4=CC=CC=C34)=C3NC4=C(C=CC=C4)C3=C12

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:26:21 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_1_Essentiality:
Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AF534707

# Drug_Target_1_GenBank_ID_Protein:
22536135

# Drug_Target_1_GeneCard_ID:
rbmD

# Drug_Target_1_Gene_Name:
rbmD

# Drug_Target_1_Gene_Sequence:
>1422 bp
ATGACGGCAGACGAGCGCGACCGCGCCCGGTCGGCGTTGCCATTCCTCGTGATCACCCAG
CTGATGATCGTGCTGGATGCCTCGATCGTGAACATCGCTCTACCCTCGATGGGCCGTGAG
CTCGGCATGGACCAGACAGGCCTGCAGTGGGTGGTCAACGCCTACACGCTCACCTTCGGC
GGCTTCCTCATGCTCGGCGGGCGCATGGCCGACCTGATCGGCCGCCGCCTCGTGTTCGTC
TCGGGCATCTGCCTGTTCGGTGCCGCCTCCCTGGCCGCCGCGCTCGCACCGGTGGCCGGT
GTGCTGGTCGCGGCCCGCGCCGTGCAGGGTCTCTCGGCGGCCGTCGCCTCCGCCGCCGCG
TTGTCGATCATCGTCGCGACGTTTCCGGAGGGTAAGGGGCGCAACCAGGCGCTCGCGATG
TGGGGGGCCGTCAGCGGCGTCGGTGGTGCCGTCGGCGTGTTGCTCGGCGGCGTGCTGACC
TCGGGGCCCGGCTGGCCGTGGATCTTCTACATCAACGTCCCTATCGTCGTCGTGGTCGTG
CTCGGGGTGTTCCGCAGCGTGTCCGGCGCTCGCGGCGACACGCGGGGCAGGCTCGACGTC
GCCGGTGCCGTCACGCTCACCGGTGGCTTGACGTTGTTGGTCTACGCCATCGTGAGCGGC
CAGTCGGGCGACCCCGTCACGATCCTGCTCGCACTGGGTCTCGCCGTCGTGCTGCTGGTG
AGCTTCTTCCTCGTGCAGCGCAAGGTGCGTGAACCTCTCGTCCCGCTGTCGTCGTTCCGC
AACCGCAACCTCTCCGTCGCCAGTGTCGTCGGCCTCTTCGCGGGTGCCGCGCCGTACGCG
ATGTTCTTCCTGCTCTCGCTGCACCTGCAGAACGTCGTGGGTCTCACCCCGCTGCAGACA
GGGCTCGGGTTCCTGCCCGTGTCGTTGATCTCGATGGTGGGCGCCGCCGCGCTGGCGCCG
CTGGCGATGGCCAGGATCGGCATGCGGTTCACGTTGCTCCTGAGCCTCGGCGTGCTGGCC
GTCGGTCTCGTCCTGCTGTCCCGCCTCACCGAGGAGGACGGCTTCGGCGCCACCGTCGCC
GGGCAGCTGGTCGCCGGTCTCGGCCTGGGCACGACCTTCGTCGCCGTGACGACGGCCGCC
GTCGCGGGACTCGCGGAGAACGAGTCGGGCCTGGCGTCGGGCCTGATCAACACCGCACAG
CAGCTGGGTGGCGCGCTGGGGCTCGGTGCGCTGGCGGCGCTGTCCGGTGCGTACTCGGCG
GCCGAGCTCGCGAAGGAGCCGCCGGTCTCCGAGGTGGCCGCGCTGTCCAGCGGATACCAG
GTGGCGTTCCTGGGTGCCGCCGTTTTCGCCGTGGCCGGCGCCCTGATCGCGCTGGCGTTG
CCCCGGCGCGAGTCAGTGCCGGCGACGACACCACACGAGTGA

# Drug_Target_1_General_Function:
Coenzyme transport and metabolism

# Drug_Target_1_General_References:
11983340	Sanchez C, Butovich IA, Brana AF, Rohr J, Mendez C, Salas JA: The biosynthetic gene cluster for the antitumor rebeccamycin: characterization and generation of indolocarbazole derivatives. Chem Biol. 2002 Apr;9(4):519-31.
12617516	Onaka H, Taniguchi S, Igarashi Y, Furumai T: Cloning of the staurosporine biosynthetic gene cluster from Streptomyces sp. TP-A0274 and its heterologous expression in Streptomyces lividans. J Antibiot (Tokyo). 2002 Dec;55(12):1063-71.
12619684	Onaka H, Taniguchi S, Igarashi Y, Furumai T: Characterization of the biosynthetic gene cluster of rebeccamycin from Lechevalieria aerocolonigenes ATCC 39243. Biosci Biotechnol Biochem. 2003 Jan;67(1):127-38.
14763561	Onaka H, Taniguchi S, Ikeda H, Igarashi Y, Furumai T: pTOYAMAcos, pTYM18, and pTYM19, actinomycete-Escherichia coli integrating vectors for heterologous gene expression. J Antibiot (Tokyo). 2003 Nov;56(11):950-6.
15743957	Nishizawa T, Aldrich CC, Sherman DH: Molecular analysis of the rebeccamycin L-amino acid oxidase from Lechevalieria aerocolonigenes ATCC 39243. J Bacteriol. 2005 Mar;187(6):2084-92.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
6302

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
57670.7

# Drug_Target_1_Name:
Putative FAD-monooxygenase

# Drug_Target_1_Number_of_Residues:
529

# Drug_Target_1_PDB_ID:
Not Available

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01494	FAD_binding_3

# Drug_Target_1_Protein_Sequence:
>Putative FAD-monooxygenase
MNAPIETDVLILGGGPVGMALALDLAHRQVGHLVVEQTDGTITHPRVGTIGPRSMELFRR
WGVAKQIRTAGWPGDHPLDAAWVTRVGGHEVYRIPLGTADTRATPEHTPEPDAICPQHWL
APLLAEAVGERLRTRSRLDSFEQRDDHVRATITDLRTGATRAVHARYLVACDGASSPTRK
ALGIDAPPRHRTQVFRNILFRAPELRSLLGERAALFFFLMLSSSLRFPLRALDGRGLYRL
TVGVDDASKSTMDSFELVRRAVAFDTEIEVLSDSEWHLTHRVADSFSAGRVFLTGDAAHT
LSPSGGFGMNTGIGSAADLGWKLAATLRGWAGPGLLATYEEERRPVAITSLEEANVNLRR
TMDRELPPGLHDDGPRGERIRAAVAEKLERSGARREFDAPGIHFGHTYRSSIVCGEPETE
VATGGWRPSARPGARAPHAWLTPTTSTLDLFGRGFVLLSFGTTDGVEAVTRAFADRHVPL
ETVTCHAPEIHALYERAHVLVRPDGHVAWRGDHLPAELGGLVDKVRGAA

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Not Available

# Drug_Target_1_SwissProt_ID:
Q8KI25

# Drug_Target_1_SwissProt_Name:
Q8KI25_NOCAE

# Drug_Target_1_Synonyms:
SubName: Putative monooxygenase
SubName: Putative polyketide hydroxylase
SubName: RebC

# Drug_Target_1_Theoretical_pI:
7.28

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB08036
